A 52-year-old male from Tamil Nadu presents with epistaxis and cervical lymphadenopathy. Biopsy confirms undifferentiated nasopharyngeal carcinoma (WHO type III). He is staged as T3N2M0. What is the drug of choice for induction chemotherapy in this locally advanced disease?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.